4min chapter

In Good Company with Nicolai Tangen cover image

HIGHLIGHTS: David Ricks - CEO of Eli Lilly

In Good Company with Nicolai Tangen

CHAPTER

Navigating Drug Development: U.S. vs Europe and Ethical Pricing Challenges

This chapter explores the contrasts in drug discovery and development between the U.S. and Europe, focusing on technology and regulatory differences. Additionally, it addresses the ethical dilemmas of drug pricing, balancing patient affordability with the need for profitability in innovation.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode